Corautus Genetics Cuts Loss
Corautus Genetics Inc. significantly reduced its net loss while it increased its revenue in 2004. The Atlanta-based biopharmaceutical company reported a net loss of $10.4 million on $83.3 million in revenue last year, compared with a net loss of $30.4 million on $34.7 million in revenue in 2003. Loss per share was 79 cents, compared with a loss per share of $3.31 in 2003.
Atlanta Business Chronicle (http://www.bizjournals.com/atlanta/stories/2005/03/21/daily3.html)